COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

Overview of attention for article published in Nature Reviews Rheumatology, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 2,763)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
twitter: 103 X users
facebook: 2 Facebook pages

reddit: 2 Redditors
guideline: 2 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 120 Mendeley

So far, Altmetric has seen 129 X posts from 103 X users, with an upper bound of 298,345 followers.

always mild... https://t.co/Kgx7kqpJIM

@Jana_84_ Maar in de cijfers valt het mee, omdat iedereen zich ter dege bewust was van de risico's en dus goed isoleerde etc waar mogelijk. Ik zou graag een echt literatuur survey voor je doen maar bleh hersenen. Vond wel dit goed uitziende artikel htt…

RT @ApoThera: COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations #RheumTwitter #rheumatoidarthritis #Rhe…

RT @ApoThera: COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations https://t.co/btasg5cfYx #RheumTwitter #…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 125 additional X posts.